Monopar Therapeutics Quarterly Unrecognized Tax Benefits in USD from Q4 2021 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: Monopar Therapeutics quarterly Unrecognized Tax Benefits history and growth rate from Q4 2021 to Q4 2024.
Monopar Therapeutics Unrecognized Tax Benefits for the quarter ending December 31, 2024 was $412K, a 22.6% increase year-over-year.

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$412K	+$75.9K	+22.6%	Dec 31, 2024	10-K	2025-03-31
Q4 2023	$336K	+$14.6K	+4.56%	Dec 31, 2023	10-K	2025-03-31
Q4 2022	$321K	+$218K	+212%	Dec 31, 2022	10-K	2025-03-31
Q4 2021	$103K			Dec 31, 2021	10-K	2024-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.